Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
Inclusion of prostate density with biomarkers increases prognostic ability for detecting csPCa. EV density can refine prediction of csPCa and in combination with PHID-mpMRI leads to superior specificity, thereby decreasing unnecessary biopsies.
Authors
- Vidhu B. Joshi (ORCID: https://orcid.org/0000-0002-9628-7880)
- Phillip J. Schulte (ORCID: https://orcid.org/0000-0001-6575-4741)
- Jack R. Andrews (ORCID: https://orcid.org/0000-0002-7781-3638)
- Cameron J. Britton (ORCID: https://orcid.org/0000-0003-3640-4528)
- Yohan Kim (ORCID: https://orcid.org/0000-0002-2829-1212)
- Laureano Rangel Latuche
- Ali Arafa
- Mohamed E. Ahmed (ORCID: https://orcid.org/0000-0002-0054-2710)
- R. Jeffrey Karnes (ORCID: https://orcid.org/0000-0003-2339-5925)
- Fabrice Lucien (ORCID: https://orcid.org/0000-0001-6149-345X)
Institutions
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- The Prostate
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1002/pros.24861
- Citations
- 3
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56